Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
Clinical trial NCT03184324 · COMPLETED
Trial details
- NCT number
- NCT03184324
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2018-04-18
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.